Contact UsInvestorsCareersMediaScienceContact Us

Pfizer in the UK

Pfizer has a rich heritage of working within the UK since our first facility was opened back in 1952.

HomeSciencePfizer in the UK

Over the past 70 years, we have continued to invest in the UK and are committed to working with the NHS and other healthcare organisations across the industry, developing solutions to improve the delivery of care and patient outcomes.

Supporting the NHS Ambition

We support the NHS Long Term Plan's ambition for prevention, empowering people to control their own health, harnessing new technologies and improving the quality of patient care and health outcomes. We believe these are key to help ensure a sustainable NHS and gives the government, the NHS and the pharmaceutical industry the chance to form a new relationship, truly working together to meet these challenges head-on while putting patients first.

We believe it's critical that we help ensure patients have access to new medicines, and that we support the NHS to meet growing demands, whilst delivering the skills, investment and employment opportunities that will ensure a thriving life sciences economy in the UK.


Our UK Investment

In 2022, we spent over £289 million supporting research and development carried out in the UK and contributed to 126 collaborations with universities, pharmaceutical companies, industries and others. Through collaborations with scientists, academics and clinicians, sharing knowledge, skills and expertise we aim to improve the health and lives of people in the UK and around the world. As of April 2023, we had 33 clinical trials on-going in the UK, across 95 UK sites, involving 471 patients since the trials started.

Download the 'Pfizer in the UK' fact sheet

Over 150 Pfizer medicines and vaccines are licensed for use in the UK. 

Our UK investment goes beyond our medicines. Each year we provide donations to charities, patient organisations, community organisations, academic institutions and professional societies and for over 15 years have supported the International Health Partners. We also actively support the scientists of tomorrow, through the National Apprenticeship Programme, our undergraduate placement scheme and through various STEM (Science Technology Engineering and Mathematics) and SIP (Science Industry Partnership) activities.


Business in the UK

The UK is an important location for Pfizer, with over 2,500 colleagues in four locations working across our commercial business, research and development (R&D) and manufacturing.

Our site in Sandwich is home to Pfizer’s fully automated ‘Pilot Plant’ that manufactures medicines for use in our clinical trials worldwide and is able to perform every step in the complex process of developing new medicines. Sandwich is also home to Pfizer's Worldwide Safety & Regulatory operations, where regulatory submissions, product licensing, clinical trial applications, translations, labelling and artwork for 170 markets across the globe is managed.

Our Devices Centre of Excellence in Cambridge, is another key site, specialising in the design and development of medicines 'delivery devices', such as auto-injectors and injector pens.

Our Locations

Sandwich, Kent 
Home to Pfizer's automated pilot plant, manufacturing medicines for Pfizer clinical trials worldwide

Walton Oaks, Surrey 
Pfizer's UK commercial headquarters

Hurley, Berkshire 
Global and regional operations

Devices Centre of Excellence, Cambridge
Specialists in the design and development of medicines delivery devices

Our History

Pfizer has a rich heritage of working within the UK since our first facility was opened back in 1952. 

Anti-Counterfeit Lab

Patient safety is our highest priority which is why we have a dedicated team tackling counterfeit medicine across the globe.

Devices Centre of Excellence

Our Devices Centre of Excellence specialises in the design and development of devices for delivery of medicines, such as auto-injectors or injector pens. 

Global Regulatory Affairs

After successful clinical trials, new medicines or treatments need to be licensed and approved before they can be made available to patients.

Medicinal Sciences, Pharmaceutical Sciences Small Molecule Team

Transforming experimental molecules into medicines for clinical trials. 

Material Characterisation Team

Helping ensure Pfizer medicines are consistently manufactured to the highest possible standards.

PP-UNP-GBR-4762 / May 2023
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.